Literature DB >> 18443088

Burkholderia pseudomallei type III secretion system mutants exhibit delayed vacuolar escape phenotypes in RAW 264.7 murine macrophages.

Mary N Burtnick1, Paul J Brett, Vinod Nair, Jonathan M Warawa, Donald E Woods, Frank C Gherardini.   

Abstract

Burkholderia pseudomallei is a facultative intracellular pathogen capable of surviving and replicating within eukaryotic cells. Recent studies have shown that B. pseudomallei Bsa type III secretion system 3 (T3SS-3) mutants exhibit vacuolar escape and replication defects in J774.2 murine macrophages. In the present study, we characterized the interactions of a B. pseudomallei bsaZ mutant with RAW 264.7 murine macrophages. Following uptake, the mutant was found to survive and replicate within infected RAW 264.7 cells over an 18-h period. In addition, high levels of tumor necrosis factor alpha (TNF-alpha), interleukin-6 (IL-6), granulocyte-macrophage colony-stimulating factor (GM-CSF), and RANTES, but not IL-1alpha and IL-1beta, were detected in culture supernatants harvested from infected monolayers. The subcellular location of B. pseudomallei within infected RAW 264.7 cells was determined, and as expected, the bsaZ mutant demonstrated early-vacuolar-escape defects. Interestingly, however, experiments also indicated that this mutant was capable of delayed vacuolar escape. Consistent with this finding, evidence of actin-based motility and multinucleated giant cell formation were observed between 12 and 18 h postinfection. Further studies demonstrated that a triple mutant defective in all three B. pseudomallei T3SSs exhibited the same phenotype as the bsaZ mutant, indicating that functional T3SS-1 and T3SS-2 did not appear to be responsible for the delayed escape phenotype in RAW 264.7 cells. Based upon these findings, it appears that B. pseudomallei may not require T3SS-1, -2, and -3 to facilitate survival, delayed vacuolar escape, and actin-based motility in activated RAW 264.7 macrophages.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18443088      PMCID: PMC2446725          DOI: 10.1128/IAI.00263-08

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  45 in total

1.  Caspase-1 dependent macrophage death induced by Burkholderia pseudomallei.

Authors:  Guang Wen Sun; Jinhua Lu; Shazib Pervaiz; Wei Ping Cao; Yunn-Hwen Gan
Journal:  Cell Microbiol       Date:  2005-10       Impact factor: 3.715

2.  Multinucleated giant cell formation and apoptosis in infected host cells is mediated by Burkholderia pseudomallei type III secretion protein BipB.

Authors:  Supaporn Suparak; Wannapa Kespichayawattana; Ashraful Haque; Anna Easton; Suwat Damnin; Ganjana Lertmemongkolchai; Gregory J Bancroft; Sunee Korbsrisate
Journal:  J Bacteriol       Date:  2005-09       Impact factor: 3.490

3.  Type VI secretion is a major virulence determinant in Burkholderia mallei.

Authors:  Mark A Schell; Ricky L Ulrich; Wilson J Ribot; Ernst E Brueggemann; Harry B Hines; Dan Chen; Lyla Lipscomb; H Stanley Kim; Jan Mrázek; William C Nierman; David Deshazer
Journal:  Mol Microbiol       Date:  2007-06       Impact factor: 3.501

4.  Effects of Burkholderia pseudomallei and other Burkholderia species on eukaryotic cells in tissue culture.

Authors:  V S Harley; D A Dance; B S Drasar; G Tovey
Journal:  Microbios       Date:  1998

Review 5.  Melioidosis: epidemiology, pathophysiology, and management.

Authors:  Allen C Cheng; Bart J Currie
Journal:  Clin Microbiol Rev       Date:  2005-04       Impact factor: 26.132

6.  Efflux-mediated aminoglycoside and macrolide resistance in Burkholderia pseudomallei.

Authors:  R A Moore; D DeShazer; S Reckseidler; A Weissman; D E Woods
Journal:  Antimicrob Agents Chemother       Date:  1999-03       Impact factor: 5.191

7.  Type III secretion system cluster 3 is required for maximal virulence of Burkholderia pseudomallei in a hamster infection model.

Authors:  Jonathan Warawa; Donald E Woods
Journal:  FEMS Microbiol Lett       Date:  2005-01-01       Impact factor: 2.742

8.  The type II O-antigenic polysaccharide moiety of Burkholderia pseudomallei lipopolysaccharide is required for serum resistance and virulence.

Authors:  D DeShazer; P J Brett; D E Woods
Journal:  Mol Microbiol       Date:  1998-12       Impact factor: 3.501

9.  Intracellular survival of Burkholderia pseudomallei.

Authors:  A L Jones; T J Beveridge; D E Woods
Journal:  Infect Immun       Date:  1996-03       Impact factor: 3.441

10.  Identification of a bacterial factor required for actin-based motility of Burkholderia pseudomallei.

Authors:  Mark P Stevens; Joanne M Stevens; Robert L Jeng; Lowrie A Taylor; Michael W Wood; Pippa Hawes; Paul Monaghan; Matthew D Welch; Edouard E Galyov
Journal:  Mol Microbiol       Date:  2005-04       Impact factor: 3.501

View more
  54 in total

1.  Comparative assessment of the intracellular survival of the Burkholderia pseudomallei bopC mutant.

Authors:  Varintip Srinon; Sunsiree Muangman; Nithima Imyaem; Veerachat Muangsombut; Natalie R Lazar Adler; Edouard E Galyov; Sunee Korbsrisate
Journal:  J Microbiol       Date:  2013-08-30       Impact factor: 3.422

2.  Burkholderia mallei cluster 1 type VI secretion mutants exhibit growth and actin polymerization defects in RAW 264.7 murine macrophages.

Authors:  Mary N Burtnick; David DeShazer; Vinod Nair; Frank C Gherardini; Paul J Brett
Journal:  Infect Immun       Date:  2009-11-02       Impact factor: 3.441

Review 3.  Human Melioidosis.

Authors:  I Gassiep; M Armstrong; R Norton
Journal:  Clin Microbiol Rev       Date:  2020-03-11       Impact factor: 26.132

4.  Regulation of type VI secretion system during Burkholderia pseudomallei infection.

Authors:  Yahua Chen; Jocelyn Wong; Guang Wen Sun; Yichun Liu; Gek-Yen Gladys Tan; Yunn-Hwen Gan
Journal:  Infect Immun       Date:  2011-06-13       Impact factor: 3.441

5.  Construction of aminoglycoside-sensitive Burkholderia cenocepacia strains for use in studies of intracellular bacteria with the gentamicin protection assay.

Authors:  Mohamad A Hamad; Alexander M Skeldon; Miguel A Valvano
Journal:  Appl Environ Microbiol       Date:  2010-03-26       Impact factor: 4.792

6.  Dissection of the Burkholderia intracellular life cycle using a photothermal nanoblade.

Authors:  Christopher T French; Isabelle J Toesca; Ting-Hsiang Wu; Tara Teslaa; Shannon M Beaty; Wayne Wong; Minghsun Liu; Imke Schröder; Pei-Yu Chiou; Michael A Teitell; Jeff F Miller
Journal:  Proc Natl Acad Sci U S A       Date:  2011-07-05       Impact factor: 11.205

7.  Burkholderia cenocepacia J2315 escapes to the cytosol and actively subverts autophagy in human macrophages.

Authors:  Souhaila Al-Khodor; Kimberly Marshall-Batty; Vinod Nair; Li Ding; David E Greenberg; Iain D C Fraser
Journal:  Cell Microbiol       Date:  2013-11-06       Impact factor: 3.715

8.  Innate immune recognition of Yersinia pseudotuberculosis type III secretion.

Authors:  Victoria Auerbuch; Douglas T Golenbock; Ralph R Isberg
Journal:  PLoS Pathog       Date:  2009-12-04       Impact factor: 6.823

9.  Functional characterization of Burkholderia pseudomallei trimeric autotransporters.

Authors:  Cristine G Campos; Matthew S Byrd; Peggy A Cotter
Journal:  Infect Immun       Date:  2013-05-28       Impact factor: 3.441

10.  Burkholderia pseudomallei isocitrate lyase is a persistence factor in pulmonary melioidosis: implications for the development of isocitrate lyase inhibitors as novel antimicrobials.

Authors:  Erin J van Schaik; Marina Tom; Donald E Woods
Journal:  Infect Immun       Date:  2009-07-20       Impact factor: 3.441

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.